Non-Small Cell Lung Cancer - Completely Resectable
1 clinical trials · Condition
◉ Watch Non-Small Cell Lung Cancer - Completely Resectable
| Record | Firm | Date |
|---|---|---|
| DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer (NCT00298298) | AVAX Technologies | 2006-01-01 |
Track Non-Small Cell Lung Cancer - Completely Resectable automatically
Every clearance here is in the API, with alerts when new ones post.